A pharmaceutical composition containing amlodipine and its application in the preparation of anti-stroke drugs
A technology of levoamlodipine and its composition, which is applied in the field of cerebrovascular drugs, can solve the problem of no golden eriodictine anti-stroke, and achieve the effects of reduced adverse reaction rate, reduced side effects, and low toxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] 40 healthy male clean-grade Wistar rats, body weight 250-300g. The rats were randomly divided into the following five groups: normal control group, model control group, golden eriodictine group, amlodipine group, and golden eriodactyl-ammonium chloride group, with 8 rats in each group. After the test started, each group was intragastrically given the corresponding test substance in the following doses:
[0021] Normal control group: 0.5% sodium carboxymethylcellulose solution at 10mL / kg;
[0022] Model control group: 0.5% sodium carboxymethylcellulose solution at 10mL / kg;
[0023] Aureotin group: 90mg / kg aureotin (dissolve aureotin in 0.5% sodium carboxymethylcellulose solution);
[0024] Amlodipine group: 1 mg / kg of levamlodipine (dissolve levamlodipine besylate in 0.5% sodium carboxymethylcellulose solution);
[0025] Jinsheng-amlodipine group: 45mg / kg of golden eriodictyrin and 0.5mg / kg of levamlodipine (dissolve levamlodipine besylate and golden eriodictine in 0....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com